CONEXXENCE
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CONEXXENCE, covering 2025-03-25 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Conexxence (denosumab) — Fresenius Kabi Deutschland GmbH